Morgan Stanley lowered the firm’s price target on MarketAxess (MKTX) to $204 from $209 and keeps an Equal Weight rating on the shares. Healthy transactional activity across brokers and exchanges in Q4 drives modest positive revision risk, notes the analyst in a preview. The analyst is raising Q4 EPS estimates by 5% on average, leaving the firm in-line with consensus, the analyst noted.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MKTX:
- MarketAxess price target lowered to $205 from $212 at Argus
- MarketAxess price target lowered to $167 from $176 at BofA
- MarketAxess buybacks will be ‘highly accretive,’ says William Blair
- MarketAxess Holdings: Promising Growth and Strategic Initiatives Drive Buy Rating
- MarketAxess Announces Stock Repurchase Increase